US approves first generic competitor to Mylan’s EpiPen
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring […]
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring […] GEORGE TOWN, Cayman Islands–(BUSINESS WIRE)August 09, 2018 –Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”) a wholly owned subsidiary of Highland Therapeutics […] July 30, 2018 — The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use […] RALEIGH, N.C., July 3, 2018 — Merz North America announced today that the U.S. Food and Drug Administration (FDA) has […] June 25, 2018 — The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment […] (HealthDay)—The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and […]approves
US approves first generic competitor to Mylan’s EpiPen
FDA Approves Jornay PM
FDA Approves Azedra
FDA Approves Xeomin (incobotulinumtoxinA) for Adult Patients with Sialorrhea (Excessive Drooling)
FDA Approves Epidiolex
FDA approves first generic under-the-tongue suboxone
Copyright © 2025